GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Retail - Defensive » Eastwood Bio-Medical Canada Inc (TSXV:EBM) » Definitions » Sloan Ratio %

Eastwood Bio-Medical Canada (TSXV:EBM) Sloan Ratio % : 0.00% (As of Oct. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Eastwood Bio-Medical Canada Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Eastwood Bio-Medical Canada's Sloan Ratio for the quarter that ended in Oct. 2024 was 0.00%.

As of Oct. 2024, Eastwood Bio-Medical Canada has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Eastwood Bio-Medical Canada Sloan Ratio % Historical Data

The historical data trend for Eastwood Bio-Medical Canada's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eastwood Bio-Medical Canada Sloan Ratio % Chart

Eastwood Bio-Medical Canada Annual Data
Trend Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24
Sloan Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -69.75 -24.44 - -

Eastwood Bio-Medical Canada Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Eastwood Bio-Medical Canada's Sloan Ratio %

For the Food Distribution subindustry, Eastwood Bio-Medical Canada's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eastwood Bio-Medical Canada's Sloan Ratio % Distribution in the Retail - Defensive Industry

For the Retail - Defensive industry and Consumer Defensive sector, Eastwood Bio-Medical Canada's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Eastwood Bio-Medical Canada's Sloan Ratio % falls into.


;
;

Eastwood Bio-Medical Canada Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Eastwood Bio-Medical Canada's Sloan Ratio for the fiscal year that ended in Oct. 2024 is calculated as

Sloan Ratio=(Net Income (A: Oct. 2024 )-Cash Flow from Operations (A: Oct. 2024 )
-Cash Flow from Investing (A: Oct. 2024 ))/Total Assets (A: Oct. 2024 )
=(-0.456--0.015
-0)/0.274
=-160.95%

Eastwood Bio-Medical Canada's Sloan Ratio for the quarter that ended in Oct. 2024 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Oct. 2024 )
=(-0.456--0.016
-0)/0.274
=-160.58%

Eastwood Bio-Medical Canada's Net Income for the trailing twelve months (TTM) ended in Oct. 2024 was -0.054 (Jan. 2024 ) + -0.13 (Apr. 2024 ) + -0.116 (Jul. 2024 ) + -0.156 (Oct. 2024 ) = C$-0.46 Mil.
Eastwood Bio-Medical Canada's Cash Flow from Operations for the trailing twelve months (TTM) ended in Oct. 2024 was -0.001 (Jan. 2024 ) + 0.011 (Apr. 2024 ) + -0.018 (Jul. 2024 ) + -0.008 (Oct. 2024 ) = C$-0.02 Mil.
Eastwood Bio-Medical Canada's Cash Flow from Investing for the trailing twelve months (TTM) ended in Oct. 2024 was 0 (Jan. 2024 ) + 0 (Apr. 2024 ) + 0 (Jul. 2024 ) + 0 (Oct. 2024 ) = C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eastwood Bio-Medical Canada  (TSXV:EBM) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Oct. 2024, Eastwood Bio-Medical Canada has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Eastwood Bio-Medical Canada Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Eastwood Bio-Medical Canada's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Eastwood Bio-Medical Canada Business Description

Traded in Other Exchanges
N/A
Address
4871 Shell Road, Suite 1130, Richmond, BC, CAN, V6X 3Z6
Eastwood Bio-Medical Canada Inc is a Canadian company engaged in the development and commercialization of safe and effective treatment for non-insulin dependent diabetes mellitus. The company is engaged in natural health supplement distribution company. It has its geographic presence in U.S., Canada and Asia. The company generates maximum revenue from Asia.
Executives
Yunji Kim Senior Officer
Youngsoo Kim Director or Senior Officer of 10% Security Holder

Eastwood Bio-Medical Canada Headlines

No Headlines